Brief: Axcella’S Late-Breaker Data From Axa1125-003 Clinical Study Presented At EASL Digital International Liver Congress
27/08/2020 13:10
Aug 27 (Reuters) - Axcella Health Inc AXLA.O :
* AXCELLA’S LATE-BREAKER DATA FROM AXA1125-003 CLINICAL
STUDY
PRESENTED AT THE EASL DIGITAL INTERNATIONAL LIVER CONGRESS
Source text for Eikon: ID:nBw44CByha
Further company coverage: AXLA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Axcella Health
See all newsAxcella Health Inc expected to post a loss of $1.25 a share - Earnings Preview
Brief: Axcella Health Inc- On Oct 4, Co Received Notice From Nasdaq That Co Had Regained Compliance With Nasdaq
Brief: Axcella Announces Reverse Stock Split Effective September 19, 2023
U.S. STOCKS ON THE MOVE-PDD Holdings, Catalent, Best Buy
Brief: Axcella Granted Patent For Long Covid Fatigue Treatment